These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15354106)

  • 1. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials.
    Sedrakyan A; Treasure T; Elefteriades JA
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):442-8. PubMed ID: 15354106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving clinical outcomes in coronary artery bypass graft surgery.
    Sedrakyan A
    Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S19-23. PubMed ID: 16227192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy outcomes of preoperative aspirin in patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis.
    Ma X; Ma C; Yun Y; Zhang Q; Zheng X
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):97-113. PubMed ID: 24212980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
    Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
    Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
    Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
    Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study.
    Øvrum E; Tangen G; Tølløfsrud S; Ringdal MA; Øystese R; Istad R
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):545-8. PubMed ID: 20067988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial).
    Benedetto U; Altman DG; Gerry S; Gray A; Lees B; Angelini GD; Flather M; Taggart DP;
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29502105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens.
    Lemmer JH; Dilling EW; Morton JR; Rich JB; Robicsek F; Bricker DL; Hantler CB; Copeland JG; Ochsner JL; Daily PO; Whitten CW; Noon GP; Maddi R
    Ann Thorac Surg; 1996 Dec; 62(6):1659-67; discussion 1667-8. PubMed ID: 8957369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
    Alderman EL; Levy JH; Rich JB; Nili M; Vidne B; Schaff H; Uretzky G; Pettersson G; Thiis JJ; Hantler CB; Chaitman B; Nadel A
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):716-30. PubMed ID: 9806378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant aprotinin in coronary artery bypass graft operations.
    Green D; Sanders J; Eiken M; Wong CA; Frederiksen J; Joob A; Palmer A; Trowbridge A; Woodruff B; Moerch M
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):963-70. PubMed ID: 7475162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation.
    Levy JH
    Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S15-9. PubMed ID: 16227191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of aprotinin on coronary artery bypass graft patency.
    Laub GW; Riebman JB; Chen C; Adkins MS; Anderson WA; Fernandez J; McGrath LB
    Chest; 1994 Nov; 106(5):1370-5. PubMed ID: 7525162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
    Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.
    Mangano DT; Miao Y; Vuylsteke A; Tudor IC; Juneja R; Filipescu D; Hoeft A; Fontes ML; Hillel Z; Ott E; Titov T; Dietzel C; Levin J; ;
    JAMA; 2007 Feb; 297(5):471-9. PubMed ID: 17284697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
    Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.